WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics
Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.
Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:
Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.
More Articles
Patient Leader Erika Hanson Brown Urges the Senate Finance Committee to #RepealDeviceTax
Recently, the Senate Finance Committee Health Tax Task Force held a meeting to discuss the medical device tax. While the 2.3%…
Read MorePatient Leader Spotlight: Mark Judge
Cancer recovery is brutal. Five years ago, I had no idea how difficult this journey would be when…
Read MoreMen’s Health Awareness Week
In the United States, men are less likely than women to visit their healthcare providers. Regular screenings are essential for…
Read MoreThe Value of Focused Ultrasound: Thomas’ Story
When Dr. Gluck told Thomas he had early-stage prostate cancer, all Thomas could hear was the word “cancer.” Cancer had taken…
Read More